MLICM
CC icon

Metropolitan Life Insurance Company (MetLife)’s Chemours CC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-33,025
Closed -$1.11M – 2318
2021
Q4 		$1.11M Sell
33,025
-1,116
-3% -$34.8K 0.02% 888
2021
Q3 		$992K Sell
34,141
-1,233
-3% -$39.9K 0.01% 953
2021
Q2 		$1.23M Buy
35,374
+4,176
+13% +$138K 0.02% 852
2021
Q1 		$871K Buy
31,198
+1,724
+6% +$45.9K 0.01% 1056
2020
Q4 		$731K Sell
29,474
-745
-2% -$17.7K 0.01% 1100
2020
Q3 		$632K Sell
30,219
-1,600
-5% -$30.9K 0.01% 1048
2020
Q2 		$488K Sell
31,819
-11,719
-27% -$148K 0.01% 1216
2020
Q1 		$386K Sell
43,538
-2,363
-5% -$34.1K 0.01% 1207
2019
Q4 		$830K Buy
45,901
+284
+0.6% +$4.72K 0.01% 1006
2019
Q3 		$682K Sell
45,617
-9,907
-18% -$161K 0.01% 1099
2019
Q2 		$1.33M Sell
55,524
-1,084
-2% -$31.9K 0.02% 735
2019
Q1 		$2.1M Sell
56,608
-1,343
-2% -$48.9K 0.04% 472
2018
Q4 		$1.64M Sell
57,951
-1,954
-3% -$61.8K 0.03% 540
2018
Q3 		$2.36M Sell
59,905
-643
-1% -$28.1K 0.04% 425
2018
Q2 		$2.69M Sell
60,548
-1,340
-2% -$66.7K 0.04% 367
2018
Q1 		$3.01M Buy
61,888
+389
+0.6% +$19.4K 0.04% 326
2017
Q4 		$3.08M Sell
61,499
-120,758
-66% -$6.33M 0.04% 331
2017
Q3 		$9.22M Buy
182,257
+437
+0.2% +$20.6K 0.06% 295
2017
Q2 		$6.89M Sell
181,820
-107,143
-37% -$4.23M 0.05% 382
2017
Q1 		$11.1M Buy
288,963
+164,860
+133% +$4.96M 0.08% 242
2016
Q4 		$2.74M Sell
124,103
-5,006
-4% -$103K 0.02% 855
2016
Q3 		$2.07M Sell
129,109
-2,844
-2% -$32.5K 0.02% 945
2016
Q2 		$1.09M Buy
131,953
+122,845
+1,349% +$1.09M 0.01% 1213
2016
Q1 		$64K Sell
9,108
-154,112
-94% -$774K ﹤0.01% 2448
2015
Q4 		$875K Buy
163,220
+828
+0.5% +$5.29K 0.01% 1256
2015
Q3 		$1.05M Buy
+162,392
New +$1.7M 0.01% 1166

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CC Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Chemours (CC) in Q1 2022, closing a stake of 33,025 shares — an estimated $1.11M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CC in Q3 2015 and held it in 26 quarters. The position peaked at $11.1M in Q1 2017. 481 funds tracked by Wall St. Rank hold CC as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 33,025 Chemours shares in Q1 2022, an estimated $1.11M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Chemours in Q3 2015 and held it in 26 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Chemours position peaked at $11.1M in Q1 2017.
  • 481 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.